Successful tapering of dupilumab in atopic dermatitis with low disease activity: pragmatic daily practice study from the BioDay registry

被引：0
|
作者：
不详
机构：
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 189卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：II / II
页数：1
相关论文
共 38 条
  • [1] Successful tapering of dupilumab in patients with atopic dermatitis with low disease activity: a large pragmatic daily practice study from the BioDay registry
    Spekhorst, Lotte S.
    Boesjes, Celeste M.
    Loman, Laura
    Zuithoff, Nicolaas P. A.
    Bakker, Daphne S.
    Kamphuis, Esme
    Kamsteeg, Marijke
    Haeck, Inge M.
    Oosting, Albert J.
    Van Lumig, Paula P. M.
    Van Lynden-Van Nes, Anneke M. T.
    Tupker, Ron A.
    Flinterman, Annebeth
    Garritsen, Floor M.
    Touwslager, Wouter R. H.
    De Bruin-Weller, Marjolein S.
    Schuttelaar, Marie-Louise A.
    De Graaf, Marlies
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (03) : 327 - 335
  • [2] Dupilumab in daily practice for the treatment of pediatric atopic dermatitis: 28-week clinical and biomarker results from the BioDay registry
    Kamphuis, Esme
    Boesjes, Celeste M.
    Loman, Laura
    Bakker, Daphne S.
    Poelhekken, Mila
    Zuithoff, Nicolaas P. A.
    Kamsteeg, Marijke
    Romeijn, Geertruida L. E.
    van Wijk, Femke
    de Bruin-Weller, Marjolein S.
    de Graaf, Marlies
    Schuttelaar, Marie L. A.
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2022, 33 (12)
  • [3] Risk factors for conjunctivitis in atopic dermatitis patients treated with dupilumab: results from the bioday registry
    Achten, R.
    Van der Rijst, L.
    Bakker, D.
    Spekhorst, L.
    Boesjes, C.
    Zuithoff, N.
    Knol, E.
    Van Luijk, C.
    De Boer, J.
    Thijs, J.
    De Graaf, M.
    De Bruin-Weller, M.
    ALLERGY, 2021, 76 : 11 - 11
  • [4] EFFECT OF UPADACITINIB ON HAND ECZEMA IN PATIENTS WITH ATOPIC DERMATITIS: DAILY PRACTICE DATA FROM THE BIODAY REGISTRY
    Kamphuis, Esme
    Loman, Laura
    Schuttelaar, Marie-Louise
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 36 - 36
  • [5] Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis Long-term Results From the Daily Practice BioDay Registry
    Spekhorst, Lotte S.
    de Graaf, Marlies
    Zuithoff, Nicolaas P. A.
    van den Reek, Juul M. P. A.
    Kamsteeg, Marijke
    Boesjes, Celeste M.
    Romeijn, Geertruida L. E.
    Loman, Laura
    Haeck, Inge
    Oosting, Albert J.
    De Boer-Brand, Astrid
    Touwslager, Wouter R. H.
    Flinterman, Annebeth
    Van Lynden-van Nes, Anneke M. T.
    Gostynski, Antoni H.
    de Bruin-Weller, Marjolein S.
    Schuttelaar, Marie-Louise
    JAMA DERMATOLOGY, 2022, 158 (09) : 1048 - 1056
  • [6] DUPILUMAB DRUG SURVIVAL AND ASSOCIATED PREDICTORS IN MODERATE-TO-SEVERE ATOPIC DERMATITIS; LONG-TERM RESULTS FROM THE DAILY PRACTICE BIODAY REGISTRY
    Spekhorst, Lotte S.
    de Graaf, Marlies
    Zuithoff, Nicolaas P. A.
    van Den Reek, Juul M. P. A.
    Kamsteeg, Marijke
    Boesjes, Celeste M.
    Romeijn, Geertruida L. E.
    Loman, Laura
    Haeck, Inge
    Oosting, Albert J.
    de Boer-Brand, Astrid
    Touwslager, Wouter R. H.
    Flinterman, Annebeth
    van Lynden-Van Nes, Anneke M. T.
    Gostynski, Antoni H.
    de Bruin-Weller, Marjolein S.
    Schuttelaar, Marie-Louise
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 37 - 38
  • [7] Experiences from daily practice of upadacitinib treatment on atopic dermatitis with a focus on hand eczema: Results from the BioDay registry
    Kamphuis, Esme
    Loman, Laura
    Han, Henry L.
    Romeijn, Geertruida L. E.
    Politiek, Klaziena
    Schuttelaar, Marie L. A.
    CONTACT DERMATITIS, 2023, 88 (05) : 351 - 362
  • [8] Eczema control and treatment satisfaction in atopic dermatitis patients treated with dupilumab - a cross-sectional study from the BioDay registry
    Oosterhaven, Jart A. F.
    Spekhorst, Lotte S.
    Zhang, Junfen
    Voorberg, Angelique N.
    Romeijn, Geertruida L. E.
    Boesjes, Celeste M.
    de Graaf, Marlies
    de Bruin-Weller, Marjolein S.
    Schuttelaar, Marie L. A.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (04) : 1986 - 1989
  • [9] Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry
    Boesjes, Celeste M.
    van der Gang, Liana F.
    Zuithoff, Nicolaas P. A.
    Bakker, Daphne S.
    Spekhorst, Lotte S.
    Haeck, Inge
    Kamsteeg, Marijke
    de Graaf, Marlies
    de Bruin-Weller, Marjolein S.
    ACTA DERMATO-VENEREOLOGICA, 2023, 103
  • [10] Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry
    Ariens, Lieneke F. M.
    van der Schaft, Jorien
    Spekhorst, Lotte S.
    Bakker, Daphne S.
    Romeijn, Geertruida L. E.
    Kouwenhoven, Tessa A.
    Kamsteeg, Marijke
    Voorberg, Angelique N.
    Oosting, Albert J.
    de Ridder, Ilona
    Sloeserwij, Annemieke
    Haeck, Inge
    Thijs, Judith L.
    Schuttelaar, Marie L. A.
    De Bruin-Weller, Marjolein S.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (04) : 1000 - 1009
1234